DIABETIC MACULAR EDEMA

This study is testing whether levosulpiride, a medication that increases prolactin hormone levels, can improve vision and reduce retinal damage in people with diabetic retinopathy and macular edema. Researchers will compare the drug against a placebo in 120 participants aged 40-6…

This study is testing a new, long-acting eye implant called EYP-1901 against the standard aflibercept injections for diabetic macular edema (DME), a common cause of vision loss in people with diabetes. The main goal is to see if the implant can control the disease just as well wh…

This is a first-in-human study to check the safety and early signs of effectiveness of a new eye injection called OCU200 for diabetic macular edema, a condition that causes vision loss. The study will enroll up to 24 adults with diabetes and vision loss from this specific eye swe…

This study is testing if a new, long-acting eye implant called EYP-1901 can control vision loss from diabetic macular edema as well as standard aflibercept injections, but with far fewer treatments. It will involve about 240 adults with the condition, comparing the implant's effe…

This early-stage study is testing whether an oral medication called Kamuvudine-9 (K9) is safe and can improve vision in people with diabetic macular edema (DME). DME is a swelling in the back of the eye that is a common cause of vision loss in people with diabetes. A small group …

This early-stage study is testing the safety and initial effects of a new oral medication called MS-553 for diabetic macular edema, a condition where fluid leaks into the eye, harming vision. It will enroll 45 adults with diabetes who have this specific eye swelling and have not …

This study is testing a new eye injection called RO7446603 to see if it is safe and can help improve vision in people with diabetic macular edema, a common cause of vision loss in diabetes. Researchers will give the injection alone or combined with other approved eye medications.…

This study aims to understand how well the eye injection drug faricimab works and how safe it is in everyday medical practice in China. It will follow 1,000 patients with diabetic macular edema, retinal vein occlusion, or neovascular age-related macular degeneration who are alrea…

This study is testing a small, refillable implant placed in the eye to continuously deliver a medicine (ranibizumab) for diabetic macular edema, a leading cause of vision loss. It compares getting medicine from this implant every 6 months to receiving a standard eye injection eve…

This study compares two common laser treatment schedules for a serious diabetic eye complication that can cause blindness. Researchers want to see if getting all the laser treatment in one session is as safe and effective as spreading it over several visits. They're enrolling 40 …

This study is collecting information on how well the eye injection drug faricimab works for people with wet age-related macular degeneration or diabetic macular edema in real-world doctor's offices. It will follow 850 patients for 2 years to see how their vision changes, how ofte…

This study aims to understand how certain substances in the blood relate to changes seen in detailed eye scans for people with diabetic macular edema (DME), a vision-threatening condition. Researchers will observe 150 patients who are either receiving standard eye injections/impl…